EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioactivated Glucoraphanin Exerts a Potential Protective Effect in an In Vitro Model of Parkinson’s Disease: A Transcriptomic Study

Agnese Gugliandolo iD, Claudia Muscarà iD, Alessia Floramo iD, Veronica Argento iD, Luca Tagliavento iD, Francesco Meneguzzo iD, Daniele Perenzoni, Fulvio Mattivi iD, Emanuela Mazzon, Luigi Chiricosta iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Agnese Gugliandolo und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Imidoesters, Parkinson Disease, Glucosinolates, Neuroprotective Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministry of Health, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Oxidative stress is involved in disease pathogenesis, with the consequent damage to DNA. Nowadays, phytocompounds attract much interest for their capacity to modulate some of the pathogenic mechanisms of PD. Glucosinolates (GLs) and their derivatives, isothiocyanate (ITC), obtained by GLs hydrolysis by myrosinase (MYR), showed neuroprotective properties. In this study, we evaluated the protective effects of pre- and post-treatment with the GL glucoraphanin (GRA) bioactivated with MYR in an in vitro model of PD, namely differentiated SH-SY5Y cells treated with the toxin MPP+. With this aim, we performed transcriptomic analysis using next-generation sequencing (NGS). We observed that GRA + MYR pre-treatment modulated Biological Process (BP) of Gene Ontology (GO) and Reactome pathways associated with oxidative stress response and DNA repair mechanisms. In the post-treatment group, BP and pathways associated with DNA processes were also overrepresented in association with those correlated to oxidative stress. Indeed, some differentially expressed genes associated with oxidative stress response were upregulated, such as SOD1, whose protein levels also increased. The results of this exploratory study suggested that GRA + MYR may induce protective effects and, in particular, pre-treatment may modulate genes involved in DNA repair, while the post-treatment may exert a protective action against oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImidoestersParkinson DiseaseGlucosinolatesNeuroprotective AgentsTranscriptomeIsothiocyanatesOximesSulfoxidesHumansOxidative StressGene Expression ProfilingCell Line, TumorGlycoside Hydrolases

Stichwörter der Autor:innen

Parkinson’s diseaseglucoraphaninglucosinolatesisothiocyanatesmyrosinasenext-generation sequencingsulforaphanetranscriptome

Substanzen

ImidoestersglucoraphaninOximesSulfoxidesGlucosinolatesNeuroprotective AgentsIsothiocyanatesthioglucosidaseGlycoside Hydrolases

Autor:innen und Institutionen

  • IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
  • HyRes Srl, Via Salvator Rosa 18, 82100 Benevento, Italy.
  • CNR-IBE, Via Madonna del Piano 10, 50019 Sesto Fiorentino, Italy.
  • Department of Food Quality and Nutrition, Research and Innovation Centre, Fondazione Edmund Mach (FEM), Via E. Mach 1, 38098 San Michele all'Adige, Italy.
  • Center for Food Metabolomics and Bioactives Development (CSMETAB), 38098 Trento, Italy.
  • Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Via Dei Vestini, 31, 66100 Chieti, Italy.

ORCID-Profile: Agnese Gugliandolo, Claudia Muscarà, Alessia Floramo, Veronica Argento, Luca Tagliavento, Francesco Meneguzzo, Fulvio Mattivi, Luigi Chiricosta

Förderung

  • Ministero della Salute
  • Ministry of Health, Italy

Zitieren

APA

Gugliandolo, A., Muscarà, C., Floramo, A., Argento, V., Tagliavento, L., Meneguzzo, F., Perenzoni, D., Mattivi, F., Mazzon, E., & Chiricosta, L. (2026). Bioactivated Glucoraphanin Exerts a Potential Protective Effect in an In Vitro Model of Parkinson’s Disease: A Transcriptomic Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188232

Vancouver

Gugliandolo A, Muscarà C, Floramo A, Argento V, Tagliavento L, Meneguzzo F, et al. Bioactivated Glucoraphanin Exerts a Potential Protective Effect in an In Vitro Model of Parkinson’s Disease: A Transcriptomic Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188232

BibTeX
@article{Gugliandolo2026,
  author = {Gugliandolo, Agnese and Muscarà, Claudia and Floramo, Alessia and Argento, Veronica and Tagliavento, Luca and Meneguzzo, Francesco and Perenzoni, Daniele and Mattivi, Fulvio and Mazzon, Emanuela and Chiricosta, Luigi},
  title = {Bioactivated Glucoraphanin Exerts a Potential Protective Effect in an In Vitro Model of Parkinson’s Disease: A Transcriptomic Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188232}
}
Kostenlos starten →